
Scientists studying the gene editing technology CRISPR-Cas9 have discovered the technique appears to frequently cause genetic damage that may slip …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

